Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CRY1 Antibodies:
anti-Mouse (Murine) CRY1 Antibodies:
anti-Rat (Rattus) CRY1 Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal CRY1 Primary Antibody for IHC, WB - ABIN2788200
Currie, Doherty, Sillar: Deep-brain photoreception links luminance detection to motor output in Xenopus frog tadpoles. in Proceedings of the National Academy of Sciences of the United States of America 2016
CRYs' C termini are essential for nuclear localization but not necessary for the suppression of CLOCK/BMAL1 (show ARNTL Antibodies) activation
we investigated the structure/function relationships of Xenopus laevis CRY1 (xCRY1) and xCRY2 (show CRY2 Antibodies) in cultured cells
Cry1 is expressed in the olfactory bulb of newborn and juvenile rabbits.
Our findings suggest that CLOCK and CRY1 polymorphisms might be involved in individual susceptibility to abdominal obesity in Chinese Han population.
Knockout-rescue embryonic stem cell-derived mouse reveals that CRY1 determines circadian period through both its degradation-dependent and -independent pathways.
The present study identified USP7 (show USP7 Antibodies) and TDP-43 (show TARDBP Antibodies) as the regulators of CRY1 and CRY2 (show CRY2 Antibodies), underscoring the significance of the stability control process of CRY (show CRY2 Antibodies) proteins for period determination in the mammalian circadian clockwork.
Altered CRY1 and CRY2 (show CRY2 Antibodies) expression patterns and the interplay with the genetic landscape in colon cancer cells may underlie phenotypic divergence.
possible circadian rhythm in full-term placental expression
Given the distinct characteristics of the C-terminal tails of the CRY1 and CRY2 (show CRY2 Antibodies) proteins, our study addresses a long-standing hypothesis that the ratio of these two CRY (show CRY2 Antibodies) molecules affects the clock period.
Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NFkappaB pathway
Collectively, these data show that KPNB1 (show KPNB1 Antibodies) is required for timely nuclear import of PER/CRY (show CRY2 Antibodies) in the negative feedback regulation of the circadian clock.
these observations suggest a biologically plausible season-dependent association between SNPs at CRY1, CRY2 (show CRY2 Antibodies) and MTNR1B (show MTNR1B Antibodies) and glucose homeostasis.
CRY1 and CRY2 (show CRY2 Antibodies) variants showed nominal association with the metabolic syndrome components, hypertension and triglyceride levels.
hnRNP Q (show SYNCRIP Antibodies) binds to mCry1 mRNA via the 5'UTR (show UTS2R Antibodies). Furthermore, hnRNP Q (show SYNCRIP Antibodies) inhibits the translation of mCry1 mRNA, leading to altered rhythmicity in the mCRY1 protein profile.
In vivo knockdown of Rfk (show RFK Antibodies), Riboflavin (vitamin B2) kinase essential for FAD (show FANCD2 Antibodies) synthesis, altered the expression rhythms of CRY1, CRY2 (show CRY2 Antibodies), and PER1 (show PER1 Antibodies)
Cryptochrome 1 in retinal cone photoreceptors suggests a novel functional role in mammals.
polyamines control the circadian period in cultured cells and animals by regulating the interaction between the core clock repressors PER2 (show PER2 Antibodies) and CRY1
Data show that cryptochrome Cry1 and Cry2 (show CRY2 Antibodies) expression must be circadian and appropriately phased to support rhythms, and arginine vasopressin (AVP (show AVP Antibodies)) receptor signaling is required to impose circuit-level circadian function.
uncovered a novel biological role for CUL4A (show CUL4A Antibodies)-DDB1-CDT2 E3 ligase that regulates molecular circadian behaviors via promoting ubiquitination-dependent degradation of CRY1
Data suggest that cryptochromes (Cry1 and Cry2 (show CRY2 Antibodies)) mediate periodic binding of Ck2b (show CSNK2B Antibodies) (casein kinase 2beta) to Bmal1 (aryl hydrocarbon receptor nuclear translocator-like (show ARNTL Antibodies) protein) and thus inhibit Bmal1 (show ARNTL Antibodies)-Ser90 phosphorylation by Ck2a (show CSNK2A1 Antibodies) (casein kinase 2alpha).
Exposure to blue light is required for an in vivo-association of CRY1 and CRY2 (show CRY2 Antibodies) with COP1.
Data suggest that cry1 mutation L407F exhibits hyperactivity which is not related to a higher FADH occupancy of the photoreceptor but is caused by a structural alteration close to the ATP-binding site.
Nitrogen signaling functions as a modulator of nuclear CRY1 protein abundance, as well as the input signal for the central circadian clock to interfere with the normal flowering process.
Data show that the effect of 3-bromo-7-nitroindazole (3B7N) treatment on gene expression in cryptochromes cry1cry2 is considerably smaller than that in the wild type, indicating that 3B7N specifically interrupts cryptochrome function in the control of seedling development in a light-dependent manner.
These data illustrate that in vivo modulation by metabolites in the cellular environment may play an important role in cryptochrome signaling.
For growth under a canopy, where blue light is diminished, CRY1 and CRY2 perceive this change and respond by directly contacting two bHLH transcription factors, PIF4 and PIF5.
CRY1 represses auxin biosynthesis in response to elevated temperature through PIF4.
CRY1 inhibits hypocotyl elongation in blue light through CNT1-mediated repression of the auxin/BR/GAresponsive gene expression.
Reactive oxygen species formation results from cry1 activation and induces cell death in insect cell cultures.
The study shows that ATP binding and aspartate protonation enhance photoinduced electron transfer in plant CRY1.
This gene encodes a flavin adenine dinucleotide-binding protein that is a key component of the circadian core oscillator complex, which regulates the circadian clock. The encoded protein is widely conserved across plants and animals. Loss of the related gene in mouse results in a shortened circadian cycle in complete darkness.
cryptochrome 1 (photolyase-like)
, cryptochrome 2 (photolyase-like)
, cryptochrome 1